Stocks and Investing Stocks and Investing
Thu, March 10, 2022
[ 12:00 AM ] - WOPRAI
Charles Duncan Maintained (ACAD) at Buy with Increased Target to $37 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Aaron Rakers Upgraded (ANET) to Buy and Held Target at $160 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Mark Lear Maintained (APA) at Hold with Increased Target to $42 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Lucas Pipes Upgraded (AMR) to Strong Buy and Increased Target to $155 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Steve Enders Maintained (ASAN) at Buy with Decreased Target to $61 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Mark Murphy Downgraded (ASAN) to Sell and Decreased Target to $32 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Brent Bracelin Maintained (ASAN) at Buy with Decreased Target to $55 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Rishi Jaluria Maintained (ASAN) at Hold with Decreased Target to $38 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Joe Goodwin Maintained (ASAN) at Buy with Decreased Target to $63 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Douglas Harter Maintained (ARR) at Hold with Decreased Target to $45 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (ADUS) at Buy with Increased Target to $125 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Biju Perincheril Maintained (BLDP) at Hold with Increased Target to $11 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Shyam Patil Maintained (BMBL) at Buy with Decreased Target to $33 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Mark Lear Maintained (BSM) at Hold with Increased Target to $13 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Mark Lear Maintained (BRY) at Hold with Increased Target to $11 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Rosivach Maintained (CBRE) at Buy with Decreased Target to $116 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Brad Erickson Maintained (CARG) at Buy with Increased Target to $56 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Krisztina Katai Maintained (CASY) at Strong Buy with Increased Target to $259 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Initiated (AVA) at Hold and Held Target at $47 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Liam Fitzpatrick Maintained (AU) at Strong Buy with Increased Target to $28 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Matthew Hedberg Maintained (BASE) at Buy with Decreased Target to $27 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Sanjit Singh Maintained (BASE) at Hold with Decreased Target to $22 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Brad Reback Maintained (BASE) at Strong Buy with Decreased Target to $25 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Raimo Lenschow Maintained (BASE) at Buy with Decreased Target to $26 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Jeff Van Sinderen Maintained (CDXC) at Strong Buy with Decreased Target to $8 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Michael Rehaut Maintained (CCS) at Buy with Decreased Target to $75 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Eric Joseph Initiated (CCCC) at Buy and Held Target at $43 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Mark Palmer Maintained (SSSS) at Strong Buy with Decreased Target to $16 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Boone Maintained (SOND) at Buy with Decreased Target to $180 on, Mar 10th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Catanzaro Maintained (SNSE) at Buy with Decreased Target to $10 on, Mar 10th, 2022

Joseph Catanzaro Maintained (SNSE) at Buy with Decreased Target to $10 on, Mar 10th, 2022


Published on 2024-10-27 20:01:57 - WOPRAI, Joseph Catanzaro
  Print publication without navigation


Joseph Catanzaro of Piper Sandler, Maintained "Sensei Biotherapeutics, Inc." (SNSE) at Buy with Decreased Target from $12 to $10 on, Mar 10th, 2022.

Joseph, nor any peers, have made any analyst calls on SNSE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources